Featured Spotlight: Charles Parker

This week, LS Associates would like to Spotlight Charles Parker 

• February 1, 2023

This week, LS Associates would like to Spotlight Charles Parker Charles P.

Charles has had a robust 20 years of experience in publicly traded biopharma companies and private equity organizations. He started his career at BDO USA and eventually left public accounting to lean into close partnerships with clients needing internal support during their key inflection points. Charles offers a proficient technical understanding of U.S. GAAP, financial reporting and analysis, SEC filings, SOX controls, strategic planning, large team accounting operations, acquisitions and divestitures, stock compensation and restructurings. Charles specializes in operational efficiency, such to simplify and focus financial operations and reporting processes. He has been a key member of two IPO teams with listings on the NASDAQ and NYSA, in addition to private equity, debt offerings and business combinations for healthcare companies.

Charles has accomplished significant feats within healthcare-related companies. He successfully completed two IPOs as a VP of finance and has guided one of the nation’s more prominent behavioral healthcare companies through a $600 million Series C offering, and later a SPAC transaction as a Corporate Controller. Charles is a financial leader whose extensive experience in company readiness lays the groundwork for smooth internal operations, adequate accounting and financial teams, internal controls, audit preparedness and execution, and more.

We are a member of the global LifeSci Partner platform that has been providing valuable executive advisory services since 2009.